These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1849157)

  • 21. Treatment of cytomegalovirus retinitis with zidovudine and ganciclovir in patients with AIDS: outcome and toxicity.
    Millar AB; Miller RF; Patou G; Mindel A; Marsh R; Semple SJ
    Genitourin Med; 1990 Jun; 66(3):156-8. PubMed ID: 2164492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compassionate use: a story of ethics and science in the development of a new drug.
    Buhles WC
    Perspect Biol Med; 2011; 54(3):304-15. PubMed ID: 21857123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 42-year-old lung transplant patient with ganciclovir-resistant cytomegalovirus (CMV) infection.
    Basgoz N
    Transpl Infect Dis; 1999 Sep; 1(3):218-25. PubMed ID: 11428992
    [No Abstract]   [Full Text] [Related]  

  • 24. CMV resistance: "more complicated than we thought".
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):37-9. PubMed ID: 11363529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CMV retinitis treated with ganciclovir [9(1,3-dihydroxy-2-propoxymethyl) guanine] in patients with AIDS.
    Bach MC; Hedstrom PS
    Ann Ophthalmol; 1987 Oct; 19(10):369-73,375. PubMed ID: 2825580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ganciclovir therapy for opportunistic cytomegalovirus disease in AIDS.
    Jacobson MA
    AIDS Clin Rev; 1990; ():149-63. PubMed ID: 1964576
    [No Abstract]   [Full Text] [Related]  

  • 27. Four dually resistant human cytomegalovirus strains from AIDS patients: single mutations in UL97 and UL54 open reading frames are responsible for ganciclovir- and foscarnet-specific resistance, respectively.
    Baldanti F; Sarasini A; Silini E; Barbi M; Lazzarin A; Biron KK; Gerna G
    Scand J Infect Dis Suppl; 1995; 99():103-4. PubMed ID: 8668930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of cytomegalovirus diseases.
    Vogel JU; Scholz M; Cinatl J
    Intervirology; 1997; 40(5-6):357-67. PubMed ID: 9675640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
    Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
    Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ganciclovir in the treatment of CMV infections in patients with AIDS.
    Lopez-Fiesco A; Peredo-Lopez MA; Estrada JL; Vargas E; Zamora G; Villarreal C
    Proc West Pharmacol Soc; 1991; 34():323-7. PubMed ID: 1664960
    [No Abstract]   [Full Text] [Related]  

  • 31. [Resistance of cytomegalovirus to ganciclovir: rapid detection of the mutations 460 of the UL97 phosphotransferase].
    Alain S; Mazeron MC; Vadam C; Honderlick P; Thouvenot D; Freymuth F; Fillet AM; Carquin J; Sanson-Le Pors MJ
    Pathol Biol (Paris); 1996 May; 44(5):456-60. PubMed ID: 8758494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
    Martin BK; Ricks MO; Forman MS; Jabs DA;
    Clin Infect Dis; 2007 Apr; 44(7):1001-8. PubMed ID: 17342657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurologic prognosis of cytomegalovirus polyradiculomyelopathy in AIDS.
    Cohen BA; McArthur JC; Grohman S; Patterson B; Glass JD
    Neurology; 1993 Mar; 43(3 Pt 1):493-9. PubMed ID: 8383823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ganciclovir treatment failure in adult allogeneic hematopoietic stem cell transplant recipients with cytomegalovirus infection--a single centre experience].
    Vejražková E; Hubáček P; Kutová R; Plíšková L; Košťál M; Štěpánová V; Zavřelová A; Radocha J; Malá E; Žák P
    Epidemiol Mikrobiol Imunol; 2015 Sep; 64(3):160-8. PubMed ID: 26448304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study.
    Hochster H; Dieterich D; Bozzette S; Reichman RC; Connor JD; Liebes L; Sonke RL; Spector SA; Valentine F; Pettinelli C
    Ann Intern Med; 1990 Jul; 113(2):111-7. PubMed ID: 2163228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CMV pneumonia and response to ganciclovir treatment in an AIDS patient.
    Lundgren JD; Vestbo J; Junge J; Mathiesen LR
    Respir Med; 1991 Sep; 85(5):437-9. PubMed ID: 1661905
    [No Abstract]   [Full Text] [Related]  

  • 37. Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
    Jabs DA; Martin BK; Forman MS; Dunn JP; Davis JL; Weinberg DV; Biron KK; Baldanti F;
    J Infect Dis; 2001 Jan; 183(2):333-337. PubMed ID: 11120934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Globular changes in cytomegaloviral inclusions after Ganciclovir treatment.
    Hruban Z; Kuzo R; Heimann P; Weisenberg E; Hruban RH
    Arch Virol; 1989; 108(3-4):287-93. PubMed ID: 2481432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.
    Wagstaff AJ; Bryson HM
    Drugs; 1994 Aug; 48(2):199-226. PubMed ID: 7527325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update in management of ganciclovir-resistant cytomegalovirus infection.
    Avery RK
    Curr Opin Infect Dis; 2008 Aug; 21(4):433-7. PubMed ID: 18594298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.